Scott Wilkie - Concepedia

Author

Scott Wilkie

King's College Hospital NHS Foundation Trust

Also Known As

S Wilkie, S. D. Wilkie, S. Wilkie, Scott D. Wilkie, Scott Wilkie

Publications

Citations

H-Index

Concepts

All Affiliations

King's College Hospital NHS Foundation Trust King's College London Barnet and Chase Farm NHS Hospitals Trust National Health Service Institute of Cancer Research

About

Scott Wilkie is an author at King's College Hospital NHS Foundation Trust specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.1K
2	Cell Biology	5	5	989
3	Education	1	1	19
4	Natural Sciences	1	1	79
5	Anesthesia	1	1	16

Scott Wilkie

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling Scott Wilkie, May CI van Schalkwyk, Steve Hobbs, Journal of Clinical Immunology Breast OncologyMedicineDual TargetingImmune Checkpoint InhibitorBreast Cancer	2012	480
Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor Scott Wilkie, Gianfranco Picco, Julie Foster, The Journal of Immunology	2008	344
Binding to serine 65‐phosphorylated ubiquitin primes Parkin for optimal <scp>PINK</scp> 1‐dependent phosphorylation and activation Agne Kazlauskaite, R.J. Martinez-Torres, Scott Wilkie, EMBO Reports	2015	241
Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4 Scott Wilkie, S. Burbridge, Laura Chiapero-Stanke, Journal of Biological Chemistry ImmunologyIl-4 Receptor AlphaImmunologic MechanismAntigen ProcessingCd4 T Cell Responses	2010	190
Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity? Sjoukje J. C. van der Stegen, David M. Davies, Scott Wilkie, The Journal of Immunology Cell TherapyTherapeutic OpportunityAdaptive Immune SystemT-regulatory CellImmunology	2013	128
Trafficking of CAR-Engineered Human T Cells Following Regional or Systemic Adoptive Transfer in SCID Beige Mice Ana C. Parente‐Pereira, Jerome Burnet, David H. Ellison, Journal of Clinical Immunology Knockout MouseCell TherapyXenotransplantationT-regulatory CellImmunology	2011	112
Flexible Targeting of ErbB Dimers That Drive Tumorigenesis by Using Genetically Engineered T Cells David M. Davies, Julie Foster, Sjoukje J. C. van der Stegen, Molecular Medicine	2012	111
pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F Yat Peng Chew, Mark Ellis, Scott Wilkie, Oncogene Signal TransductionSignaling PathwayCell DivisionCell RegulationNatural Sciences	1998	79
Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin Ana C. Parente‐Pereira, Lynsey M. Whilding, Nancy Brewig, The Journal of Immunology	2013	60
RB activation defect in tumor cell lines Cristina Broceño, Scott Wilkie, Sibylle Mittnacht Proceedings of the National Academy of Sciences	2002	49

Page 1